Shortess v. Touro Infirmary
This text of 520 So. 2d 389 (Shortess v. Touro Infirmary) is published on Counsel Stack Legal Research, covering Supreme Court of Louisiana primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
Marna B. SHORTESS
v.
TOURO INFIRMARY, et al.
Supreme Court of Louisiana.
*390 Boris F. Navratil, James E. Toups, Jr., Breazeale, Sachse & Wilson, Baton Rouge, for applicant.
Edward A. Rodrique, Jr., Robert I. Baudouin, Boggs, Loehn & Rodrigue, Harold A. Thomas, Robert D. Ford, Thomas, Hayes & Beahn, New Orleans, Paul H. Dué, Dué, Smith & Caballero, Baton Rouge, for respondents.
WATSON, Justice.
The questions presented are: (1) whether a hospital is liable for a 1980 sale of defective blood even though the contaminating hepatitis virus could not have been detected by testing; (2) whether prescription was interrupted against the blood center which supplied the blood; and, if so, (3) whether the blood center is liable.
FACTS
On November 26, 1980, plaintiff, Marna B. Shortess, underwent a surgical procedure at Touro Infirmary in which her spine was fused and a Harrington Rod was inserted to correct severe scoliosis. During the surgery, Marna was given five units of packed red blood cells which were contaminated with hepatitis virus resulting in chronic hepatitis and damage to her liver.
A claim against Touro was filed with a medical review panel on December 21, 1981. Over a year later, on December 22, 1982, Touro revealed that the five units of blood had been purchased from the Blood Center for Southeast Louisiana, Inc. After the medical review panel rejected Marna's claim against Touro on March 9, 1983, this suit was filed against Touro Infirmary and the Blood Center on May 31, 1983. The trial court granted Touro a directed verdict on the ground that it did not prepare the tainted blood and no negligence had been established. The jury returned verdicts against the remaining defendants, the Blood Center for Southeast Louisiana, Inc. and St. Paul Fire and Marine Insurance Company, awarding $25,000 to Marna Shortess and $10,000 to her husband.[1]
The Blood Center filed a peremptory exception of prescription in the Court of Appeal which was sustained. The Court of Appeal also dismissed plaintiffs' suit against Touro holding that Touro was not a manufacturer and could not have known the blood was defective.[2] A writ was granted to review the judgment.[3]
Touro Infirmary maintains a blood bank. At the time of this surgery, Touro obtained blood from donors, which it processed and tested. However, Touro obtained the larger portion of its blood from the Blood Center for Southeast Louisiana. The cards attached to the five units of blood administered to Marna show that they were cross matched by a Touro employee. Touro's patients had no way of knowing the source of their transfused blood, which could only be discovered by tracing serial numbers through Touro's card files. All patient charges for blood were through Touro, which also accepted blood donors for credit on the patient's Touro Infirmary Blood Bank account.
The Blood Center for Southeast Louisiana is a nonprofit organization which is affiliated with the American Association of Blood Banks and follows their certification and inspection procedures. It does not use paid donors. The blood is tested for hepatitis "B". An unknown agent causes hepatitis non-A/non-B, which Marna Shortess contracted. There is no test for this type *391 of hepatitis. Many of the carriers of non-A/non-B are asymptomatic and unaware that they are carriers. Ninety to ninety-five percent of all post-transfusion hepatitis is non-A/non-B.[4]
The Blood Center for Southeast Louisiana has a federal manufacturer's license to manufacture and prepare whole human blood for sale. The blood given Ms. Shortess had been treated to make red packed cells.
Following surgery, Marna Shortess initially had a good recovery. She then became weak and ill with nausea, fatigue and loss of appetite. On January 10, 1981, after she had developed severe jaundice, she saw a gastroenterologist. Testing on January 8th had revealed that she did not have hepatitis "A" or hepatitis "B" but had non-A/non-B hepatitis. The gastroenterologist said the most probable conclusion was that the non-A/non-B hepatitis was caused by the transfusion. Marna's acute condition lasted about three weeks. Later, she had a recurrence, which is characteristic of non-A/non-B hepatitis, and further recurrences. After two needle biopsies of her liver, she was diagnosed as having either chronic active hepatitis, mild, or chronic persistent hepatitis. Chronic active hepatitis may lead to cirrhosis of the liver. There is piecemeal necrosis in Marna's liver. Because non-A/non-B is a new and mysterious form of hepatitis, the prognosis is guarded. Marna's first normal liver function test was on July 3, 1985.
LIABILITY OF TOURO
Touro Infirmary sold five units of blood to Marna Shortess, which were contaminated with non-A/non-B hepatitis. "A distributor of blood is strictly liable in tort when blood he places on the market creates an unreasonable risk of harm to others and, in fact, results in injury or disease to a human being." DeBattista v. Argonaut-Southwest Ins. Co., 403 So.2d 26 at 32 (La.1981). Touro is liable for the hepatitis disease contracted by Marna Shortess.[5]
After remand,[6]Weber v. Charity Hospital of La. at New Orleans, 487 So.2d 148 (La.App. 4 Cir.1986) held that Charity Hospital, which administered blood in a closed system, charging for the blood and the service, was not strictly liable for defects in the blood. Weber is contrary to DeBattista, supra; Toups v. Sears Roebuck and Co., Inc., 507 So.2d 809 (La.1987); Faucheaux v. Alton Ochsner Medical Foundation, 470 So.2d 878 (La.1985); and Chappuis v. Sears Roebuck & Co., 358 So.2d 926 (La.1978). The responsibility of a professional vendor or distributor is the same as that of a manufacturer. The Court of Appeal opinion in Weber is overruled.
PRESCRIPTION AND LIABILITY OF BLOOD BANK
This cause of action arose on January 10, 1981, when Marna Shortess was advised she had contracted transfusion hepatitis. A claim against Touro was filed with a medical review panel on December 21, 1981, but suit was not filed until May 31, 1983. Prescription against a qualified health care provider, such as Touro, is interrupted during the deliberations of a medical review panel. LSA-R.S. 40:1299.47, subd. A.[7] This medical review panel did *392 not render its decision until March 9, 1983. Suit was timely filed against Touro within ninety days. However, the Blood Center for Southeast Louisiana, Inc., is not a qualified health care provider. Under LSA-R.S. 40:1299.41(D),[8] as interpreted in Ferguson v. Lankford, 374 So.2d 1205 (La.1979), the timely claim against Touro did not interrupt prescription against the Blood Center.
Plaintiffs urge the application of "contra non valentem agere nulla currit praescriptio", i.e., prescription does not run against a person unable to bring an action. Since one is not bound to do the impossible, a party excusably ignorant of a claim is not barred by prescription. 5 Civil Law Translations at p. 465. The doctrine is discussed at length in Plaquemines Par. Com'n Council v. Delta Dev., 502 So.2d 1034 at 1054 (La.1987).
Excusable ignorance exists when "the cause of action is not known or reasonably knowable." Plaquemines, supra, at p. 1056. Corsey v. State Dept. of Corrections, 375 So.2d 1319 (La.1979); Penn v. Inferno Manufacturing Corporation,
Free access — add to your briefcase to read the full text and ask questions with AI
Related
Cite This Page — Counsel Stack
520 So. 2d 389, 1988 La. LEXIS 636, 1988 WL 15699, Counsel Stack Legal Research, https://law.counselstack.com/opinion/shortess-v-touro-infirmary-la-1988.